-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
February 16, 2022 - In addition,
the number of reported adverse events in the nabilone/
GBP group decreased by 27% from Visits
-
effectivehealthcare.ahrq.gov/health-topics/amblyopia
-
effectivehealthcare.ahrq.gov/health-topics/flu
-
effectivehealthcare.ahrq.gov/health-topics/retinal-detachment
-
effectivehealthcare.ahrq.gov/health-topics/cervical-cancer-screening
-
effectivehealthcare.ahrq.gov/health-topics/sepsis/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-draft-report-appendix-g-2.xlsx
March 20, 2024 - RoB 2 questions
Question Number Question Text
1.1 Was the allocation sequence random?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - In addition,
the number of reported adverse events in the nabilone/
GBP group decreased by 27% from Visits
-
effectivehealthcare.ahrq.gov/health-topics/blood-sugar
-
effectivehealthcare.ahrq.gov/health-topics/mammography/
-
effectivehealthcare.ahrq.gov/health-topics/low-blood-pressure/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - In addition,
the number of reported adverse events in the nabilone/
GBP group decreased by 27% from Visits
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-e-evidence-tables.xlsx
March 25, 2024 - In addition,
the number of reported adverse events in the nabilone/
GBP group decreased by 27% from Visits
-
effectivehealthcare.ahrq.gov/health-topics/healthy-sleep